Director, US Patient Advocacy |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 06, 2024 |
Senior Manager, Purpose & Culture Communications |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
Manager, US Policy & Issues Communications |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
Associate Director, US Content & Channel Strategy |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
Manager, US Channel Operations & Publishing |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
Manager, US Reputation & Corporate Storytelling |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 05, 2024 |
Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 04, 2024 |
Director, Corporate Marketing Campaigns |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
Director, Corporate Marketing Paid Media, Partnerships & Sponsorships |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
Associate Director, Corporate Event Marketing |
Cambridge (USA) |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
Patient Engagement Lead |
İstanbul Kavacık |
Türkei |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
EA & Program Coordinator |
Beijing (Beijing) |
China |
Communications & Engagement |
Innovative Medicines |
Communications & Public Affairs |
Sep 03, 2024 |
Associate Director, Corporate Marketing Campaigns |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Aug 27, 2024 |
Associate Director, Corporate Marketing Paid Media |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Aug 27, 2024 |
Patient Support Program Nurse |
Israel |
Israel |
Innovative Medicines International & Chief Commercial Office |
Innovative Medicines |
Communications & Public Affairs |
Aug 15, 2024 |
Senior Communications Manager |
Basel (City) |
Schweiz |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Aug 06, 2024 |
Government Affairs Manager |
Moscow (City) |
Russische Foed. |
Communications & Engagement |
Innovative Medicines |
Communications & Public Affairs |
Juli 29, 2024 |
PSP specialist |
Seoul |
Südkorea |
Communications & Engagement |
Innovative Medicines |
Communications & Public Affairs |
Juli 23, 2024 |
Director, Other Radiosensitive Tumors & Rare Disease Communications |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Juli 19, 2024 |
Associate Director, Marketing Copywriter |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Juli 12, 2024 |
Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
Innovative Medicines International & Chief Commercial Office |
Innovative Medicines |
Communications & Public Affairs |
Juli 09, 2024 |
State Government Affairs & Partnerships Manager |
Western Australia (WA) |
Australien |
Innovative Medicines International & Chief Commercial Office |
Innovative Medicines |
Communications & Public Affairs |
Mai 19, 2024 |
Executive Director, Public Affairs LaCan Region |
East Hanover |
USA |
Communications & Engagement |
Corporate |
Communications & Public Affairs |
Mai 09, 2024 |
Director, Public Affairs |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
Mai 06, 2024 |
Executive Director, US Corporate Communication |
East Hanover |
USA |
Communications & Engagement |
CTS |
Communications & Public Affairs |
Mai 02, 2024 |